Hence, TR1-like CD4+ T cells show cytotoxic abilities and accumulate in LNs of CLL and DLBCL patients, making their potential pathological involvement in these malignancies very likely. This evidence concerns the gene CD4 and B-cell chronic lymphocytic leukemia.